InsiderClue
Insiders · Profile

Dolsten Mikael

Director at Agilent Technologies · President R&D at Pfizer. Filing since 6 Mar 2013. CIK 0001437590

A Agilent Technologies Director · 3 trades PFE Pfizer President R&D · 15 trades
Company
Date
Role
Action
Shares
Amount
Of holding
A Agilent Technologies
4 Sep 2026
Director
Sold at will
634
$95.97K
11.4%
A Agilent Technologies
29 May 2026
Director
Sold at will
1,600
$216.67K
22.4%
A Agilent Technologies
1 Dec 2025
Director
Sold at will
2,600
$389.51K
34.3%
PFE Pfizer
11 May 2022
President R&D
Sold, plan not stated
63,902
$3.15M
16.1%
PFE Pfizer
11 Nov 2021
President R&D
Sold, plan not stated
59,664
$3.00M
17.6%
PFE Pfizer
18 May 2020
President R&D
Sold, plan not stated
95,353
$3.60M
35.3%
PFE Pfizer
4 Mar 2019
President R&D
Sold, plan not stated
49,082
$2.14M
14.5%
PFE Pfizer
1 Mar 2019
President R&D
Sold, plan not stated
100,471
$4.38M
22.9%
PFE Pfizer
9 Mar 2018
President R&D
Sold, plan not stated
69,699
$2.55M
57.7%
PFE Pfizer
2 Mar 2018
President R&D
Sold, plan not stated
13,986
$501.40K
10.4%
PFE Pfizer
27 Feb 2018
President R&D
Sold, plan not stated
64,587
$2.39M
40.4%
PFE Pfizer
2 Mar 2017
President R&D
Sold, plan not stated
15,401
$532.10K
23.8%
PFE Pfizer
1 Mar 2017
President R&D
Sold, plan not stated
15,569
$536.82K
19.4%
PFE Pfizer
27 Feb 2017
President R&D
Sold, plan not stated
58,846
$2.02M
42.3%
PFE Pfizer
4 May 2016
President R&D
Sold, plan not stated
67,588
$2.26M
15.4%
PFE Pfizer
5 Mar 2015
President R&D
Sold, plan not stated
58,298
$2.01M
14.1%
PFE Pfizer
4 Mar 2014
President R&D
Sold, plan not stated
35,789
$1.17M
9.4%
PFE Pfizer
6 Mar 2013
President R&D
Sold, plan not stated
30,582
$859.80K
9.1%
18 decisions on file.